Storia in 7 fonti

UniQure to file gene therapy for approval, reflecting major shifts at FDA

The decision marks another regulatory U-turn following the exits of Marty Makary and Vinay Prasad, suggesting to some analysts that current FDA leadership may be more flexible in certain cases.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 mese fa

UniQure to file gene therapy for approval, reflecting major shifts at FDA

The decision marks another regulatory U-turn following the exits of Marty Makary and Vinay Prasad, suggesting to some analysts that current FDA leadership may be more flexible in certain cases.

originale

Timeline cronologica

mercoledì 17 giugno 2026·zerohedge.com
The Biology Won
The FDA blinks, giving Huntington’s patients hope—and uniQure shareholders a windfall.
mercoledì 17 giugno 2026·biopharmadive.com
UniQure to file gene therapy for approval, reflecting major shifts at FDA
The decision marks another regulatory U-turn following the exits of Marty Makary and Vinay Prasad, suggesting to some analysts that current FDA leadership may be more flexible in…

UniQure to file gene therapy for approval, reflecting major shifts at FDA

Confronto fonti

UniQure to file gene therapy for approval, reflecting major shifts at FDA

Timeline cronologica

The Biology Won

UniQure to file gene therapy for approval, reflecting major shifts at FDA

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

FDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated Approval - uniQure (NASDAQ:QURE)

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

The Biology Won

Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

FDA Signals uniQure Huntington Gene Therapy Data Could Back Accelerated Approval - uniQure (NASDAQ:QURE)

"Truly evil" FDA rejection of gene therapy overturned after Trump official ousted

In another reversal, FDA gives uniQure accelerated approval path for Huntington's gene therapy

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency